Arterial Puncture Closing Devices Compared with Standard Manual Compression after Cardiac Catheterization: Systematic Review and Meta-analysis

JAMA

Volumn 291, Issue 3, 2004, Pages 350-357

  Koreny, Maria ^a   Riedmüller, Eva ^a   Nikfardjam, Mariam ^a   Siostrzonek, Peter ^b   Müllner, Marcus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Headache Medical Center Seilerstaette   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS FISTULA; BIOMEDICAL TECHNOLOGY ASSESSMENT; BIOSIS; CLINICAL TRIAL; COCHRANE LIBRARY; COMPRESSION; DEVICE; EMBASE; FALSE ANEURYSM; HEART CATHETERIZATION; HEMATOMA; HUMAN; INTERMETHOD COMPARISON; MEDLINE; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; REVIEW;

EID: 0345872125     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.3.350     Document Type: Review

References (47)

1. Smith SC Jr, Dove JT, Jacobs AK, et al. A report from the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2001;37:2215-2239.
2. Douglas JJ, King S III. Development of balloon angioplasty. In: Hurst's the Heart, Manual of Cardiology. 10th ed. New York, NY: McGraw-Hill; 2001:327.
3. Silber S. ESC guidelines for percutaneous coronary interventions [press release]. Available at: http: //www.escardio.org/VPO/2003/Guidelines%20-%20PCI.pdf. Accessed October 25, 2003.
4. Nasser T, Mohleri EI, Wilensky R, Hathaway D. Peripheral vascular complications following coronary interventional procedures. Clin Cardiol. 1995;18:609-614.
5. Applegate R, Grabarczyk M, Little W, et al. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol. 2002;40:78-83.
6. Resnic F, Blake G, Ohno-Machado L, Selwyn A, Popma J, Rogers C. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. Am J Cardiol. 2001;88:493-496.
7. Waksman R, King S III, Douglas JJ, et al. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol. 1995;75:886-889.
8. Omoigui N, Califf R, Pieper K, et al. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Artherectomy Trial (CAVEAT-1). J Am Coll Cardiol. 1995;26:922-930.
9. Condon JV Jr, Elsner GB, Nootens MT, et al. Comparison of hemostasis time and vascular complications between the Angio-Seal hemostatic puncture closure and device and manual pressure. Circulation. 1995;92(8 suppl):1599.
10. De Swart H, Dijkman L, Van Ommen V, et al. The hemostatic puncture closure device shortens time to hemostasis and ambulation after arterial catheterization. J Coll Cardiol. 1994;24(suppl):355A.
11. Doneux P, Gach O, Martinez C, Legrand V. Femoral puncture closure devices versus manual compression after percutaneous coronary interventions. Eur Heart J. 2001;22(suppl):216.
12. Magosaki N, Hosoda S, Kawagishi N, et al. Efficacy of hemostatic puncture closing device for hemostasis and early ambulation after coronary angiography and angioplasty: results of a multicenter trial. J Cardiol. 1999;34:131-138.
13. Murray CD, Mortazavi A, Warth DC, Buchbinder M. A randomized controlled prospective study of the Angio-Seal device versus manual pressure for rapid arterial puncture closure. Circulation. 1996;94(8 suppl):1376.
14. Ward SR, Casale P, Raymond R, et al. Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Am J Cardiol. 1998;81:569-572.
15. Sievert H, Becker T, Wander T, et al. Stopping bleeding after PTCA. Zeitschrift für Kardiologie. 1999;88(suppl 2):108.
16. Kussmaul WG III, Buchbinder M, Whitlow PL, et al. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty. J Am Coll Cardiol. 1995;25:1685-1692.
17. Landis D, Crater S, Lowrie M, et al. Does the use of an absorbable femoral arterial closure device reduce length of stay and costs after diagnostic angiography compared to standard compression? Eur Heart J. 1997;18(suppl):232.
18. Seidelin P, Adelman A. Mobilization within thirty minutes of elective diagnostic coronary angiography. J Interv Cardiol. 1997;10:409-415.
19. Chevalier B, Lancelin B, Puel J, et al. Does arterial sealing device decrease the rate of local complication? Circulation. 1999;110:1-447.
20. Chevalier B, Henry M, Pilliere R, et al. Duplex scan assessment of femoral access for coronary stenting. Eur Heart J. 2000;21(suppl):642.
21. Brachmann J, Ansah M, Kosinski EJ, Schuler GC. Improved clinical effectiveness with a collagen vascular hemostasis device for shortened immobilization time following diagnostic angiography and percutaneous transluminal coronary angioplasty. Am J Cardiol. 1998;81:1502-1505.
22. Brown CL III, Freschi LA, Blincoe WA, et al. A prospective, randomized trial and cost-effectiveness study of the VasoSeal collagen plug vs manual arterial pressure in patients undergoing cardiac catheterization. Circulation. 1997;96(8 suppl):1618.
23. Camenzind E, Grossholz M, Urban P, et al. Collagen application versus manual compression. J Am Coll Cardiol. 1994;24:655-662.
24. Gwechenberger M, Katzenschlager R, Heinz G, et al. Use of a collagen plug versus manual compression for sealing arterial puncture site after cardiac catheterization. Angiology. 1997;48:121-126.
25. Silber S, Bjorvik A, Muhling H, Rosch A. Usefulness of collagen plugging with VasoSeal after PTCA as compared to manual compression with identical sheath dwell times. Cathet Cardiovasc Diagn. 1998;43:421-427.
26. Slaughter PM, Chetty R, Flintoft VF, et al. A single center randomized trial assessing use of a vascular hemostasis device vs conventional manual compression following PTCA: what are the potential resource savings? Cathet Cardiovasc Diagn. 1995;34:210-214.
27. Von Hoch F, Neumann FJ, Theiss W, Kastrati A, Schomig A. Efficacy and safety of collagen implants for haemostasis of the vascular access site after coronary balloon angioplasty and coronary stent implantation: a randomized study. Eur Heart J. 1995;16:640-646.
28. Gibbs HH, Molloy TJ, Shaftel P, Barra LA, Sanborn TA. Reduced hemostasis time and early ambulation following percutaneous transluminal coronary angioplasty using a collagen vascular hemostasis device. Aust N Z J Med. 1993;23:628.
29. Sanborn TA, Gibbs HH, Brinker JA, et al. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol. 1993;22:1273-1279.
30. Cope G, Mews G, Cumpston G, et al. Controlled trial of a vascular heamostasis device, 'Vasoseal', after coronary angioplasty. Aust N Z J Med. 1994;24:650.
31. Ellis SG. Assessment of the safety and efficacy of the Duett vascular hemostasis device. Am Heart J. 2002;143:612-619.
32. Zhang Z, Mahoney EM, Gershony G, et al. Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures. Am Heart J. 2001;142:982-988.
33. El Amine S, Teiger E, Aptecar E, Dubois-Rande JL, Pernes JM, Dupouy P. Percutaneous suture of femoral artery after diagnostic coronary angiography. Arch Mal Coeur Vaiss. 1999;92:1447-1453.
34. Gerckens U, Cattelaens N, Lampe EG, et al. Management of arterial puncture site after catheterization procedures. Am J Cardiol. 1999;83:1658-1663.
35. Noguchi T, Miyazaki S, Yasuda S, et al. A randomised controlled trial of Prostar Plus for haemostasis in patients after coronary angioplasty. Eur J Vasc Endovasc Surg. 2000;19:451-455.
36. Rickli H, Unterweger M, Sutsch G, et al. Comparison of costs and safety of a suture-mediated closure device with conventional manual compression after coronary artery interventions. Catheter Cardiovasc Interv. 2002;57:297-302.
37. Tron C, Koning R, Eltchaninoff H, Janorkar S, Douillet R, Cribier A. Femoral artery closure after PTCA. Eur Heart J, 1998;19(suppl):392.
38. Baim DS, Knopf WD, Hinohara T, et al. Suture-mediated closure of the femoral access site after cardiac catheterization. Am J Cardiol. 2000;85:864-869.
39. Moher D, Schulz K, Altman D. The CONSORT statement. JAMA. 2001;285:1987-1991.
40. Schulz K, Chalmers I, Hayes R, Altman D. Empirical evidence of bias. JAMA. 1995;273:408-412.
41. Higgins J, Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
42. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
43. Bos J, Hunink M, Mali W. Use of a collagen hemostatic closure device to achieve hemostasis after arterial puncture. J Vasc Interv Radiol. 1996;7:479-486.
44. Silber S. Hemostasis success rates and local complications with collagen after femoral access for cardiac catheterization. Am Heart J. 1998;135:152-156.
45. Dangas G, Mehran R, Kokolis S, et al. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arterial puncture closing devices. J Am Coll Cardiol. 2001;38:638-641.
46. University HealthSystem Consortium. Available at: http://www.uhc.edu. Accessed October 23, 2003.
47. ACC National Cardiovascular Database Registry. Available at: http://www.acc.org/ncdr/index .htm. Accessed November 4, 2003.